Charles K. Gayer, Chief Commercial Officer: Biocryst Pharmaceuticals BCRX Buy · Filed 24/05/15

Trade details

Type: Insider buy
Amount: $164,100
Shares · price: 30,000 sh · $5.47 a share
Held after: 307,533 sh
Stock: Biocryst Pharmaceuticals BCRX
Person: Charles K. GayerChief Commercial Officer
Trade date: 24/05/13
Filed: 24/05/15
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 8 insiders
Holding change: +10.8%

Biocryst Pharmaceuticals trades, last 26 weeks

What else happened in Biocryst Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/04/13~24/06/12

Charles K. Gayer's recent trades

No other trades yet.